Breyanzi® support in 2L+ LBCL

Cell Therapy 360 logo

Call us at +1 (888) 805-4555
Visit us at CellTherapy360.com

Cell Therapy 360® resources are designed to support eligible patients and caregivers through the Bristol Myers Squibb CAR T-cell therapy journey, from enrollment through the initial post-infusion monitoring period

Patient support navigators

Patient support navigators

Logistical 
support

Logistical support

Financial support

Financial support

Additional eligibility requirements apply. Patients may enroll in support programs offered through Cell Therapy 360 after a certified CAR T-cell therapy treatment center determines that Breyanzi is the right treatment for them.

Request a Breyanzi representative

If you have any additional questions about Breyanzi, please use the information provided below to contact a representative.

Call us at 1-800-321-1335.

2L, second-line; CAR, chimeric antigen receptor; LBCL, large B-cell lymphoma.



Bristol Myers Squibb logo

© 2025 Juno Therapeutics, Inc., a Bristol Myers Squibb company. All Rights Reserved.
BREYANZI is a trademark of Juno Therapeutics, Inc., a Bristol Myers Squibb company.
Cell Therapy 360 is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

© 2025 Bristol Myers Squibb company.

2009-US-2500226

09/2025